{"id":"NCT01076647","sponsor":"Novo Nordisk A/S","briefTitle":"Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes","officialTitle":"A 26-week Randomised, Confirmatory, Controlled, Open Label, Multicentre, Multinational Treat-to-target Trial Comparing the Efficacy and Safety of SIBA 200 U/ml Three Times Weekly Injected in the Evening and Insulin Glargine Once Daily in a Population of Insulin naïve Subjects With Type 2 Diabetes Mellitus Currently Treated With OADs Qualifying for Intensified Treatment (BEGIN™: EASY™)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-03","primaryCompletion":"2010-12","completion":"2010-12","firstPosted":"2010-02-26","resultsPosted":"2015-11-10","lastUpdate":"2017-03-06"},"enrollment":467,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec","otherNames":[]},{"type":"DRUG","name":"insulin glargine","otherNames":[]}],"arms":[{"label":"IDeg 3TW","type":"EXPERIMENTAL"},{"label":"IGlar OD","type":"ACTIVE_COMPARATOR"}],"summary":"This trial was conducted in Europe and North America. The aim of this clinical trial was to compare NN1250 (insulin degludec (IDeg)), a soluble insulin basal analogue (SIBA), with insulin glargine (IGlar), as add-on to subject's ongoing treatment with metformin and/or DPP-4 (dipeptyl peptidase 4) inhibitors, in patients with type 2 diabetes being treated with oral anti-diabetic drugs (OADs).","primaryOutcome":{"measure":"Change in Glycosylated Haemoglobin (HbA1c)","timeFrame":"Week 0, Week 26","effectByArm":[{"arm":"IDeg 3TW","deltaMin":-1.05,"sd":0.94},{"arm":"IGlar OD","deltaMin":-1.36,"sd":0.95}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":105,"countries":["United States","Bulgaria","Canada","France","Hungary","Netherlands","Romania"]},"refs":{"pmids":["24622318"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":233},"commonTop":["Diarrhoea","Headache","Nasopharyngitis"]}}